Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer


Lotan Y., Woldu S. L. , Sanli O., Black P., Milowsky M. I.

BJU INTERNATIONAL, cilt.122, ss.434-440, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 122 Konu: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1111/bju.14220
  • Dergi Adı: BJU INTERNATIONAL
  • Sayfa Sayıları: ss.434-440

Özet

ObjectivesTo model the cost-effectiveness of a biomarker-based approach to select patients for neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in muscle-invasive bladder cancer (MIBC).